MA51831B1 - Composition pour la prévention et le traitement de troubles de la pousse des cheveux - Google Patents
Composition pour la prévention et le traitement de troubles de la pousse des cheveuxInfo
- Publication number
- MA51831B1 MA51831B1 MA51831A MA51831A MA51831B1 MA 51831 B1 MA51831 B1 MA 51831B1 MA 51831 A MA51831 A MA 51831A MA 51831 A MA51831 A MA 51831A MA 51831 B1 MA51831 B1 MA 51831B1
- Authority
- MA
- Morocco
- Prior art keywords
- prevention
- treatment
- hair growth
- composition
- growth disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne l'utilisation de dérivés d'iminooxothiazolidine pour la prévention ou le traitement de troubles de la pousse des cheveux. Les dérivés d'iminooxothiazolidine peuvent être formulés en tant que compositions appropriées pour l'administration systémique ou l'application locale sur le cuir chevelu.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT201800002630A IT201800002630A1 (it) | 2018-02-13 | 2018-02-13 | Composizione per la prevenzione e il trattamento dei disturbi della crescita dei capelli |
| PCT/EP2019/053591 WO2019158607A1 (fr) | 2018-02-13 | 2019-02-13 | Composition pour la prévention et le traitement de troubles de la pousse des cheveux |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA51831A MA51831A (fr) | 2020-12-23 |
| MA51831B1 true MA51831B1 (fr) | 2023-09-27 |
Family
ID=62044904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA51831A MA51831B1 (fr) | 2018-02-13 | 2019-02-13 | Composition pour la prévention et le traitement de troubles de la pousse des cheveux |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US11793792B2 (fr) |
| EP (1) | EP3752253B1 (fr) |
| JP (1) | JP7356984B2 (fr) |
| CN (1) | CN111818973B (fr) |
| AU (1) | AU2019221535A1 (fr) |
| CA (1) | CA3090401A1 (fr) |
| DK (1) | DK3752253T3 (fr) |
| EA (1) | EA202091933A1 (fr) |
| ES (1) | ES2954733T3 (fr) |
| FI (1) | FI3752253T3 (fr) |
| HR (1) | HRP20231043T1 (fr) |
| HU (1) | HUE062748T2 (fr) |
| IL (1) | IL276669A (fr) |
| IT (1) | IT201800002630A1 (fr) |
| LT (1) | LT3752253T (fr) |
| MA (1) | MA51831B1 (fr) |
| MD (1) | MD3752253T2 (fr) |
| MX (1) | MX2020008458A (fr) |
| PL (1) | PL3752253T3 (fr) |
| PT (1) | PT3752253T (fr) |
| RS (1) | RS64581B1 (fr) |
| SG (1) | SG11202007410TA (fr) |
| SI (1) | SI3752253T1 (fr) |
| WO (1) | WO2019158607A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110882173B (zh) * | 2019-12-05 | 2022-06-17 | 西北农林科技大学 | 一种靶向毛囊干细胞防治脱发的外用型日化品配方 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| US7563813B2 (en) * | 2005-05-13 | 2009-07-21 | Wyeth | Iminothiazolidinone derivatives as SFRP-1 antagonists |
| FR2891543A1 (fr) * | 2005-10-05 | 2007-04-06 | Oreal | Composes phenyl-furyl-methyl-thiazolidine-2,4-diones ou phenyl-thienyl-methyl-thiazolidine-2,4-diones ; utilisations pour stimuler ou induire la pousse des fibres keratiniques et/ou freiner leur chute ; compositions le contenant |
| US8859616B2 (en) * | 2011-01-21 | 2014-10-14 | Allergan, Inc. | Compounds and methods for enhancing hair growth |
| FR3020951B1 (fr) | 2014-05-16 | 2016-06-17 | Pierre Fabre Dermo-Cosmetique | Association d'un tetrapeptide et d'un glyceryl ester pour le traitement de l'alopecie androgenique. |
-
2018
- 2018-02-13 IT IT201800002630A patent/IT201800002630A1/it unknown
-
2019
- 2019-02-13 WO PCT/EP2019/053591 patent/WO2019158607A1/fr active Application Filing
- 2019-02-13 FI FIEP19708402.3T patent/FI3752253T3/fi active
- 2019-02-13 SG SG11202007410TA patent/SG11202007410TA/en unknown
- 2019-02-13 CN CN201980011295.3A patent/CN111818973B/zh active Active
- 2019-02-13 MA MA51831A patent/MA51831B1/fr unknown
- 2019-02-13 LT LTEPPCT/EP2019/053591T patent/LT3752253T/lt unknown
- 2019-02-13 EA EA202091933A patent/EA202091933A1/ru unknown
- 2019-02-13 JP JP2020539722A patent/JP7356984B2/ja active Active
- 2019-02-13 ES ES19708402T patent/ES2954733T3/es active Active
- 2019-02-13 AU AU2019221535A patent/AU2019221535A1/en active Pending
- 2019-02-13 MD MDE20201271T patent/MD3752253T2/ro unknown
- 2019-02-13 MX MX2020008458A patent/MX2020008458A/es unknown
- 2019-02-13 HU HUE19708402A patent/HUE062748T2/hu unknown
- 2019-02-13 EP EP19708402.3A patent/EP3752253B1/fr active Active
- 2019-02-13 US US16/969,246 patent/US11793792B2/en active Active
- 2019-02-13 PT PT197084023T patent/PT3752253T/pt unknown
- 2019-02-13 HR HRP20231043TT patent/HRP20231043T1/hr unknown
- 2019-02-13 CA CA3090401A patent/CA3090401A1/fr active Pending
- 2019-02-13 SI SI201930616T patent/SI3752253T1/sl unknown
- 2019-02-13 DK DK19708402.3T patent/DK3752253T3/da active
- 2019-02-13 PL PL19708402.3T patent/PL3752253T3/pl unknown
- 2019-02-13 RS RS20230702A patent/RS64581B1/sr unknown
-
2020
- 2020-08-12 IL IL276669A patent/IL276669A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MA51831A (fr) | 2020-12-23 |
| JP2021513509A (ja) | 2021-05-27 |
| EA202091933A1 (ru) | 2020-12-29 |
| ES2954733T3 (es) | 2023-11-24 |
| HRP20231043T1 (hr) | 2023-12-22 |
| FI3752253T3 (fi) | 2023-09-01 |
| AU2019221535A1 (en) | 2020-10-01 |
| BR112020016211A2 (pt) | 2020-12-08 |
| US11793792B2 (en) | 2023-10-24 |
| EP3752253A1 (fr) | 2020-12-23 |
| PL3752253T3 (pl) | 2023-12-04 |
| IL276669A (en) | 2020-09-30 |
| HUE062748T2 (hu) | 2023-12-28 |
| PT3752253T (pt) | 2023-09-04 |
| DK3752253T3 (da) | 2023-09-04 |
| MX2020008458A (es) | 2022-07-19 |
| CN111818973B (zh) | 2023-08-22 |
| JP7356984B2 (ja) | 2023-10-05 |
| WO2019158607A1 (fr) | 2019-08-22 |
| US20210000801A1 (en) | 2021-01-07 |
| CA3090401A1 (fr) | 2019-08-22 |
| LT3752253T (lt) | 2023-10-10 |
| SG11202007410TA (en) | 2020-09-29 |
| RS64581B1 (sr) | 2023-10-31 |
| CN111818973A (zh) | 2020-10-23 |
| EP3752253B1 (fr) | 2023-06-14 |
| MD3752253T2 (ro) | 2023-11-30 |
| SI3752253T1 (sl) | 2023-11-30 |
| IT201800002630A1 (it) | 2019-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA54231A (fr) | Composés de 2-formyl-3-hydroxyphényloxyméthyle capables de moduler l'hémoglobine | |
| MA42410A (fr) | Oxystérols et leurs méthodes d'utilisation | |
| MA45598B1 (fr) | Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda | |
| FR3028753B1 (fr) | Gel aqueux ou hydroalcoolique de phyllosilicates synthetiques a titre d'agent viscosant, matifiant et/ou homogeneisant d'application | |
| MA40111A1 (fr) | Dérivés du tétrahydronaphtalène inhibant la protéine mcl-1 | |
| MA27728A1 (fr) | Antagonistes des recepteurs de cgrp | |
| MA38576B2 (fr) | Formulations de colchicine à libération prolongée et procédés d'utilisation de ces dernières | |
| CL2019002515A1 (es) | Juego de composiciones cosméticas para el cuidado de la piel. | |
| MA50406B1 (fr) | Inhibiteurs pyrazole de magl | |
| MA40768A (fr) | Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue | |
| MA47356B1 (fr) | Dérivés d'isochromène utiles en tant qu'inhibiteurs des phosphoinositide 3-kinases | |
| FR788811A (fr) | Compositions destinées à être appliquées sur la peau des personnes, plus particulièrement employées pour les massages et les frictions | |
| MA46229A (fr) | Composés d'hétéroaryle carboxamide en tant qu'inhibiteurs de ripk2 | |
| MA51881B1 (fr) | Dérivés d'alcool utilisés en tant qu'agents d'ouverture du canal potassique kv7 | |
| FR2885491B1 (fr) | Traitement de la secheresse keratinique par des glycerides | |
| MA57379B1 (fr) | Modulateurs du recepteur alpha associe aux oestrogenes (err-alpha) | |
| MA51831B1 (fr) | Composition pour la prévention et le traitement de troubles de la pousse des cheveux | |
| MA39253A1 (fr) | Composés hétéroaryle bicycliques substitués utilisés comme agonistes de rxr | |
| MA36538B1 (fr) | Utilisation de composition a base d'extraits de microalgues marines pour le traitement d'acne | |
| MA52375A1 (fr) | Inhibiteurs de cdk8/19 | |
| FR3083667B1 (fr) | Formulation d'huiles essentielles a liberation prolongee et procede de traitement de produits vegetaux au moyen de ladite formulation | |
| FR3045325B1 (fr) | Kit de maquillage comprenant au moins deux compositions | |
| MA30267B1 (fr) | Derives amides en tant que ligands de canal ionique et compositions pharmaceutiques et procedes d'utilisation de tels derives | |
| FR3015239B1 (fr) | Utilisation d'au moins un derive hydroxypropyl trialkylammonium comme agent deodorant | |
| FR3064482B1 (fr) | Composition topique de doxycycline |